Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
industrial partners. To strengthen our team, we are seeking a highly motivated researcher with a strong background in solid adsorbents/gas adsorption/separation. Project Focus The project builds on Empa’s
-
22 Apr 2026 Job Information Organisation/Company Empa Research Field Engineering » Materials engineering Physics » Computational physics Physics » Condensed matter properties Physics » Solid state
-
» Biotechnology Technology » Nanotechnology Researcher Profile Recognised Researcher (R2) Application Deadline 24 Jun 2026 - 21:59 (UTC) Country Switzerland Type of Contract Temporary Job Status Full-time Is the
-
/Brussels) Country Switzerland Type of Contract Temporary Job Status Part-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position
-
looking forward to applicants with a solid research track in protein and RNA biochemistry and a strong motivation to succeed. Indeed, we are not interested in participants, but in performers. A good command
-
Deadline 20 Mar 2026 - 22:59 (UTC) Country Switzerland Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job
-
) Application Deadline 26 Apr 2026 - 21:59 (UTC) Country Switzerland Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is
-
30 Jan 2026 Job Information Organisation/Company Swiss Federal Institute for Forest, Snow and Landscape Research WSL Research Field Environmental science » Earth science Environmental science
-
apply these capabilities to both internally designed and fabricated magnetic multilayers and nanostructures, as well as to samples provided through established international collaborations, allowing us to
-
, structural biology, and clinical research across Switzerland, Israel, Australia and the USA. The project Antibiotic treatments for M. abscessus fail in more than half of patients despite in vitro drug